Eli Lilly’s Oral GLP-1 Pill Shows Strong Phase 3 R...
Category : Clinical Trial Update 27 August 2025Eli Lilly announced positive topline results from the ATTAIN-2 Phase 3 trial of orforglipron, an ora...
Clinical Trial Update
Givinostat Shows Long-Term Benefits for Duchenne M...
Category : Clinical Trial Update 26 August 2025For families facing Duchenne muscular dystrophy (DMD), time is everything. A new study brings hope&m...
Alkermes to Showcase Phase 2 Vibrance-1 Data on Al...
Category : Clinical Trial Update 26 August 2025Alkermes plc (Nasdaq: ALKS) will present detailed results from its Vibrance-1 Phase 2 study of alixo...
Terns Pharmaceuticals Prepares Investors for Key T...
Category : Clinical Trial Update 25 August 2025Terns Pharmaceuticals (Nasdaq: TERN) is gearing up for a major milestone. Ahead of Phase 1 data expe...
$49.2M Boost for Alzheimer’s Research: Lighthouse...
Category : Clinical Trial Update 23 August 2025Alzheimer’s disease (AD) affects over 6 million Americans—and despite decades of researc...
Latest Newsletter Post
-
Correctseq’s CS-101 Marks First Bas..
29 August 2025
-
Bristol Myers Squibb to Present New..
29 August 2025
-
Evommune Starts Phase 2b Trial of E..
28 August 2025
-
Ascletis’ ASC30 Shows Strong PK Dat..
28 August 2025
-
Eli Lilly’s Oral GLP-1 Pill Shows S..
27 August 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com